Remember that notes written in the margin of a document and other informal written communications can be misconstrued and, therefore, even more damaging than formal documents. c. Contact Avient’s Legal Department at your first opportunity and document the incident. 9 HOME | TOC Updated: February 2021 North America Global Headquarters Avon Lake, United States 33587 Walker Road Avon Lake, OH, United States 44012 Toll Free: +1 866 765 9663 Phone: +1 440 930 1000 Fax: +440 930 3064 Asia Pacific Regional Headquarters Shanghai, China 2F, Block C 200 Jinsu Road Pudong, 201206 Shanghai, China Telephone: +86 (0) 21 6028 4888 Fax: +86 (0) 21 6028 4999 South America Regional Headquarters Sao Paulo, Brazil Av.

Tap water was put in a beaker, the top of the beaker was covered with a sample of the test film, and the beaker was put in a refrigerator at 4°C (39°F).

a) 米国食品医薬品局（FDA）または国際標準化機構（ISO）により「インプラント」機器として分類される医療機器、または米国薬局方（USP）または ISO 規格で定義される「パーマネント」 機器、または (b)EU指令90/385/EECの改正で定義された能動埋込型医療機器、または (c)EU指令93/42/EECの改正で定義された「長期」使用のための医療機器。

Obtain and review a report from the independent auditor at least annually: (a) regarding the independent auditor’s internal quality-control procedures; (b) regarding any material issues raised by the most recent internal quality-control review, peer review or Public Company Accounting Oversight Board review of the firm, or by any inquiry or investigation by any other governmental or professional authorities within the preceding five years respecting one or more independent audits carried out by the firm; and any steps taken to address any such issues; and (c) to assess the auditor’s independence and all relationships between the independent auditor and the Company. 2.

S&P 500 All time high of $43.34 July 1st, 2014 PolyOne Corporation Page 9 2006 2014 2015 Target “Where we were” “Where we are” (Est. in 2012) 1) Operating Income % Specialty: Global Color, Additives & Inks 1.7% 14.7% 12 – 16% Global Specialty Engineered Materials 1.1% 12.1% 12 – 16% Designed Structures & Solutions 1.4% (2012) 7.3% 8 – 10% Performance Products & Solutions 5.5% 7.7% 9 – 12% Distribution 2.6% 6.1% 6 – 7.5% 2) Specialty Platform % of Operating Income 6.0% 65% 65 – 75% 3) ROIC* 5.0% 11.3% 15% 4) Adjusted EPS Growth N/A 37% Double Digit Expansion *ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period Proof of Performance & 2015 Goals PolyOne Corporation Page 10 Continuing Earnings Growth Double Digit EPS Expansion Ongoing LSS Programs Incremental Share Buybacks Mergers & Acquisitions Continued Gross Margin Expansion Mid Single Digit Revenue Growth Accelerated Innovation & Mix Improvement PolyOne Corporation Page 11 Innovation Drives Earnings Growth *Percentage of Specialty Platform revenue from products introduced in last five years $20 $53 2006 2014 Research & Development Spending ($ millions) Specialty Platform Vitality Index Progression* 14% 27% 2006 2014 Specialty Platform Gross Margin % 20% 44% 2006 2014 Specialty Vitality Index Target ≥ 35% PolyOne Corporation Page 12 Megatrends Aligned with Key End Markets Decreasing Dependence on Fossil Fuels Protecting the Environment Improving Health and Wellness Megatrend End Markets Globalizing and Localizing Health & Wellness Transportation Packaging Consumer PolyOne Corporation Page 13 60% 94% 20% 30% 40% 50% 60% 70% 80% 90% 100% 2008 2014 Pension Funding** As of December 31, 2014 Debt Maturities & Pension Funding – 12/31/14 Net Debt / EBITDA* = 1.9x $49 $317 $600 $0 $100 $200 $300 $400 $500 $600 $700 $800 2015 2020 2023 Debt Maturities As of December 31, 2014 ($ millions) Coupon Rate: 7.500% 7.375% 5.250% ** includes US-qualified pension plans only *TTM 12/31/2014 PolyOne Corporation Page 14 Free Cash Flow and Strong Balance Sheet Fund Investment / Shareholder Return  Expanding our sales, marketing, and technical capabilities  Investing in operational and LSS initiatives (including synergy capture)  ~75% of capital expenditures fund growth initiatives Organic Growth Acquisitions Share Repurchases Dividends $0.16 $0.20 $0.24 $0.32 $0.40 $0.10 $0.20 $0.30 $0.40 $0.50 2011 2012 2013 2014 2015 Annual Dividend  Targets that expand our: • Specialty offerings • End market presence • Geographic breadth • Operating Margin  Synergy opportunities  Adjacent material solutions  Repurchased 1.6 million shares in Q4 2014  Repurchased 11.3 million shares since early 2013  8.7 million shares are available for repurchase under the current authorization PolyOne Corporation Page 15 PolyOne Core Values Innovation Collaboration Excellence PolyOne Corporation Page 16 The New PolyOne: A Specialty Growth Company Why Invest In PolyOne?

a) 米国食品医薬品局（FDA）または国際標準化機構（ISO）により「インプラント」機器として分類される医療機器、または米国薬局方（USP）または ISO 規格で定義される「パーマネント」 機器、または (b)EU指令90/385/EECの改正で定義された能動埋込型医療機器、または (c)EU指令93/42/EECの改正で定義された「長期」使用のための医療機器。

埃万特的产品不为以下目的或用途而设计，也不会宣传或预期用于以下目的或用途： (a) 被美国食品药品监督管理局（FDA）或国际标准化组织（ISO）归类为“植入”类器械的医疗器械；或美国药典（USP）或ISO标准定义的“永久”使用器械；或 (b) 经修订的欧盟指令90/385/EEC中定义的有源植入式医疗器械；或者 (c) 经修订的欧盟指令93/42/EEC中定义的“长期”使用的医疗器械。

POLYMER/CARRIER COMPATIBILITY IN PET 100 90 80 70 60 50 40 30 20 % light transmission at 500 nm Process window is opened up allowing greater process capability Carrier A: ColorMatrix advanced carrier technology (current) Carrier B: Early-mid 2000s Carrier C: Pre-2000s % dose 4.53.5 4.03.02.52.01.51.00.50 HOW LIQUID HELPS Expertly formulated liquid color systems can deliver significant benefits and greater long- term value in use than alternative colorant systems for an ever expanding range of product applications and production processes.

POLYMER/CARRIER COMPATIBILITY IN PET 100 90 80 70 60 50 40 30 20 % light transmission at 500 nm Process window is opened up allowing greater process capability Carrier A: ColorMatrix advanced carrier technology (current) Carrier B: Early-mid 2000s Carrier C: Pre-2000s % dose 4.53.5 4.03.02.52.01.51.00.50 HOW LIQUID HELPS Expertly formulated liquid color systems can deliver significant benefits and greater long- term value in use than alternative colorant systems for an ever expanding range of product applications and production processes.

Administration, Site Management, Manufacture, Laboratory, Procurement, Supply Chain Management, Engineering and Maintenance, Infrastructure, Warehouse and Transport C/Carretera.